178 Participants Needed

Sleep and Circadian Rhythm + Memory Support for Sleep Disorders

AH
Overseen ByAllison Harvey, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Berkeley
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Memory Support Intervention (MSI) for sleep disorders?

Research shows that similar treatments, like the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C), have been effective in improving sleep and mental health outcomes. Additionally, interventions targeting sleep in older adults with mild cognitive impairment have shown improvements in sleep quality, which is linked to better cognitive health.12345

Is the Sleep and Circadian Rhythm + Memory Support treatment safe for humans?

The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) has been studied in community settings, but the available research does not provide specific safety data for humans. Further studies are needed to establish its safety profile.34678

How is the Memory Support Intervention treatment different from other treatments for sleep disorders?

The Memory Support Intervention is unique because it targets both sleep and circadian rhythm disruptions, which are linked to memory issues, especially in older adults. This approach is novel as it aims to restore regular circadian rhythms, potentially preventing or slowing neurodegenerative diseases and improving cognitive function.69101112

What is the purpose of this trial?

Mental illness is often chronic, severe, and difficult to treat. Though there has been significant progress towards establishing effective and efficient interventions for psychological health problems, many individuals do not gain lasting benefits from these treatments. The Memory Support Intervention (MSI) was developed utilizing existing findings from the cognitive science literature to improve treatment outcomes. In this study, the investigators aim to conduct an open trial that includes individuals 50 years and older to assess if a novel version of the Memory Support Intervention improves sleep and circadian functioning, reduces functional impairment, and improves patient memory for treatment.

Research Team

AH

Allison G Harvey, PhD

Principal Investigator

University of California, Berkeley

Eligibility Criteria

This trial is for individuals aged 50 and older who speak English, have mobility issues, low income, and show no signs of cognitive impairment. They must be experiencing sleep or circadian disturbances but not severe untreated sleep apnea or other conditions that severely affect sleep. Participants need to consent to communication between researchers and their medical providers.

Inclusion Criteria

Low income
Consent to regular communications between the research team and the patient's medical provider/s if needed to communicate about suicide risk
English language fluency
See 5 more

Exclusion Criteria

Suicide risk sufficient to preclude treatment on an outpatient basis
Night shift work >2 nights per week in the past 3 months
I have severe sleep apnea or moderate sleep apnea with extreme daytime tiredness.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants receive TranS-C+MSI or TranS-C alone in eight 50-minute, weekly, individual sessions

8-10 weeks
8 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 months
2 visits (in-person) at 6-month and 12-month follow-up

Treatment Details

Interventions

  • Memory Support Intervention
  • Transdiagnostic Intervention for Sleep and Circadian Dysfunction
Trial Overview The study tests a new Memory Support Intervention (MSI) designed to improve treatment outcomes by enhancing patient memory. It focuses on people with mental illness suffering from sleep disorders and aims to see if MSI can better their sleep patterns, daily functioning, and memory retention.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: TranS-C+MSIExperimental Treatment2 Interventions
Transdiagnostic Intervention for Sleep and Circadian Dysfunction will be combined with the Memory Support Intervention
Group II: TranS-C aloneActive Control1 Intervention
The Transdiagnostic Sleep and Circadian Intervention will be delivered alone

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Berkeley

Lead Sponsor

Trials
193
Recruited
716,000+

Findings from Research

A six-session cognitive behavioral therapy for insomnia (CBT-I) significantly improved sleep quality in older adults with mild cognitive impairment (MCI), as shown in a study with 28 participants.
The intervention also led to improvements in executive functioning, particularly in tasks related to inhibition, suggesting that better sleep may positively influence cognitive abilities in individuals with MCI.
Neuropsychological Functioning in Older Adults with Mild Cognitive Impairment and Insomnia Randomized to CBT-I or Control Group.Cassidy-Eagle, E., Siebern, A., Unti, L., et al.[2022]
The 'Sleep Well, Think Well' (SWTW) intervention significantly improved subjective sleep quality in older adults with mild cognitive impairment (MCI), with a large effect size (Cohen's d = 0.83) based on a study of 35 participants over eight weeks.
While the SWTW program showed promise in reducing daytime sleepiness (Cohen's d = 0.70), it did not significantly impact cognitive functioning, depressive symptoms, or objective sleep measures, indicating that while sleep quality improved, other cognitive outcomes may require different interventions.
"Sleep Well, Think Well" Group Program for Mild Cognitive Impairment: A Randomized Controlled Pilot Study.Naismith, SL., Pye, J., Terpening, Z., et al.[2020]
The TranS-C intervention, when combined with usual care, significantly reduced functional impairment, psychiatric symptoms, and sleep disturbances in adults with serious mental illness, as shown in a study of 121 participants over 8 weeks.
These improvements were not only significant immediately after treatment but were also largely maintained at a 6-month follow-up, indicating the potential long-term benefits of the TranS-C approach for enhancing sleep and overall functioning.
A randomized controlled trial of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) to improve serious mental illness outcomes in a community setting.Harvey, AG., Dong, L., Hein, K., et al.[2022]

References

Neuropsychological Functioning in Older Adults with Mild Cognitive Impairment and Insomnia Randomized to CBT-I or Control Group. [2022]
"Sleep Well, Think Well" Group Program for Mild Cognitive Impairment: A Randomized Controlled Pilot Study. [2020]
A randomized controlled trial of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) to improve serious mental illness outcomes in a community setting. [2022]
Buying time: a proof-of-concept randomized controlled trial to improve sleep quality and cognitive function among older adults with mild cognitive impairment. [2018]
A transdiagnostic sleep and circadian intervention for adolescents: six-month follow-up of a randomized controlled trial. [2021]
Circadian Rhythm Changes in Healthy Aging and Mild Cognitive Impairment. [2023]
Sleep habits in mild cognitive impairment. [2021]
Outcomes of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) in a community setting: Unpacking comorbidity. [2021]
Chronobiological rhythm constraints of memory processes. [2008]
Hippocampal activity mediates the relationship between circadian activity rhythms and memory in older adults. [2022]
Non-rapid eye movement sleep instability in mild cognitive impairment: a pilot study. [2016]
12.United Statespubmed.ncbi.nlm.nih.gov
Associations of actigraphic sleep and circadian rest/activity rhythms with cognition in the early phase of Alzheimer's disease. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security